This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.08.053v1 49/3/304    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Worthley, M. I. Articles by Horowitz, J. D. Search for Related Content PubMed Articles by Worthley, M. I. Articles by Horowitz, J. D.

CLINICAL RESEARCH: CARDIOVASCULAR DISEASE AND RISK

The Deleterious Effects of Hyperglycemia on Platelet Function in Diabetic Patients With Acute Coronary Syndromes

Mediation by Superoxide Production, Resolution With Intensive Insulin Administration

Cardiology Unit, Basil Hetzel Research Institute, The Queen Elizabeth Hospital, University of Adelaide, South Australia, Australia

Manuscript received June 19, 2006; revised manuscript received August 14, 2006, accepted August 30, 2006.

^_* Reprint requests and correspondence: Dr. John D. Horowitz, Cardiology Unit, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, South Australia, Australia 5011. (Email: john.horowitz{at}adelaide.edu.au).

OBJECTIVES: This study sought to assess the determinants of platelet nitric oxide (NO) responsiveness in diabetic patients admitted with acute coronary syndromes (ACS) and the short-term effects of aggressive glycemic control on these factors.

BACKGROUND: Hyperglycemia is an independent risk factor for mortality in both diabetic patients and nondiabetic patients with ACS. The mechanism(s) underlying this observation and potential benefit from its correction remain uncertain. Although a reduction in NO bioavailability has been proposed, this remains untested in the ACS setting.

METHODS: A total of 76 diabetic patients with ACS were studied. Putative correlations between admission blood sugar level (BSL), inhibition of platelet aggregation by the NO donor sodium nitroprusside (SNP), and superoxide (O₂ ^–) were assessed. Hyperglycemic patients (n = 60) were randomized to acute glycemic control with intravenous versus subcutaneous insulin, and changes in the aforementioned parameters were compared. Plasma levels of the endogenous inhibitor of NO synthase asymmetric dimethylarginine (ADMA) were also monitored.

RESULTS: There was an inverse correlation between admission BSL and both platelet SNP response (p = 0.007) and ADMA levels (p = 0.045), and a positive correlation with O₂ ^– generation (p < 0.001). Intravenous insulin infusion resulted in a greater reduction (p < 0.001) in BSL, differentially improved platelet responsiveness to SNP (p = 0.049), and decreased O₂ ^– (p < 0.001) and ADMA levels (p = 0.049).

CONCLUSIONS: A component of platelet dysfunction in diabetic patients with ACS is impaired responsiveness to the anti-aggregatory effects of NO, probably reflecting increased NO clearance by O₂ ^–. This phenomenon is reversed by acute aggressive glycemic control. These findings provide a further rationale for use of insulin therapy in acute myocardial infarction and suggest its extension to ACS patients.

Abbreviations and Acronyms   ACS = acute coronary syndromes   ADMA = asymmetric dimethylarginine   AMI = acute myocardial infarction   BSL = blood sugar level   NO = nitric oxide   PRP = platelet-rich plasma   SC = subcutaneous

This article has been cited by other articles:

				C. Manrique, G. Lastra, J. Palmer, M. Gardner, and J. R. Sowers Review: Aspirin and Diabetes Mellitus: revisiting an old player Therapeutic Advances in Cardiovascular Disease, February 1, 2008; 2(1): 37 - 42. [Abstract] [PDF]

				R. P. Giugliano and E. Braunwald The Year in Non ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395. [Full Text] [PDF]